Woodland Care Center: Medication Storage Failure - CA
Federal inspectors visiting Woodland Care Center on April 11 found that the facility was not storing budesonide inhalation suspension according to the manufacturer's own written instructions. The drug is used to treat airway inflammation, typically in residents with asthma or chronic obstructive pulmonary disease. When it degrades, it does not always look different. It simply stops working as well, or stops working at all.
The manufacturer's prescribing guide, dated August 2024, is specific about what the medication needs. It must be kept upright. It must stay at a controlled room temperature, between 68 and 77 degrees Fahrenheit. It must be protected from light.
Those requirements do not disappear once the packaging is opened. The guide states that after an aluminum foil envelope has been opened, any unused ampules must go back inside that envelope to shield them from light. Even then, the clock is running. Opened but unused ampules are good for two weeks, and only if they stay protected. Any ampule that has already been opened for use must be used promptly, not set aside.
Inspectors reviewed the manufacturer's guide and found the facility was not meeting these conditions. The citation rated the level of harm as minimal harm or potential for actual harm, and noted that few residents were affected.
That language can obscure what is actually at stake. Budesonide delivered by inhalation reaches the lungs directly. A resident with compromised breathing who receives a degraded dose of the medication does not get a warning. Their treatment simply becomes less effective, quietly, without any visible sign that something has gone wrong. For a resident whose breathing is already labored, that gap matters.
The storage requirements exist because the drug is chemically sensitive in ways that are not always visible. Light exposure and temperature fluctuations can break down the active compound in the suspension. The ampules are small, single-use containers, and the foil envelope they come in is not incidental packaging. It is part of the storage system the manufacturer built into the product.
Woodland Care Center is a 99-bed skilled nursing facility on Corbin Avenue in Reseda, a neighborhood in the western San Fernando Valley. The April inspection covered health standards. This citation was the finding documented in the report.
The facility's provider identification number is 056066. For information on how Woodland Care Center plans to correct the deficiency, the Centers for Medicare and Medicaid Services directs inquiries to the facility or to the California state survey agency.
What the inspection report does not describe is how long the medication had been stored incorrectly, how many residents received doses from improperly stored ampules, or whether any resident experienced a change in condition that might have been connected to degraded medication. Those questions were not answered in the documents reviewed.
What it does describe is a facility where the instructions were available, printed in a manufacturer's guide that inspectors found and read during their visit, and the conditions those instructions required were not being met.
For a resident sitting with a nebulizer mask over their face, breathing in a mist they cannot see and cannot evaluate, the integrity of what is in that ampule is not something they can check. They rely on the people responsible for storing it correctly to have done so. On the day inspectors arrived at Woodland Care Center, that reliance had not been earned.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Woodland Care Center from 2025-04-11 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Corrections: We strive for accuracy in everything we publish. If you believe any fact in this article is incorrect, please contact us with details, and we will review and correct it promptly.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: October 27, 2026 · Our methodology
WOODLAND CARE CENTER in RESEDA, CA was cited for violations during a health inspection on April 11, 2025.
The drug is used to treat airway inflammation, typically in residents with asthma or chronic obstructive pulmonary disease.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.